With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Novartis opens up a path of research to protect proteins that guard against cancer.

Ambitious scientist accelerates research into African genomic diversity and health challenges with internship

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Compounds block a protein involved in many cancers by cementing it shut.

I sometimes overlook what I’ve achieved or overcome to arrive at this point in my career. The opportunities I’ve embraced, the advice I’ve received and the heartfelt decisions I’ve made. So sharing my journey with you was an opportunity to pause and reflect, strengthening my belief that change is not always easy, but it can be very rewarding.

In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.